Related Experiment Video
Updated: Apr 5, 2026

07:45
Tear-Derived Exosomal miR-15a as New Diagnostic Tool for Diabetic Retinopathy
Published on: December 30, 2025
684
Type 1 Diabetes and MicroRNA: It's Complicated
Curtis R Warren1, Chad A Cowan2
1Department of Stem Cell and Regenerative Biology and Harvard Stem Cell Institute, Harvard University, Cambridge, MA 02138, USA.
Cell Metabolism
|August 6, 2015
Summary
Researchers studied protective mechanisms in type 1 diabetes survivors using stem cells. They discovered new interactions between microRNA and the DNA damage checkpoint pathway, offering insights into disease resilience.
Area of Science:
- Immunology
- Genetics
- Cell Biology
Background:
- Type 1 diabetes is an autoimmune disorder characterized by insufficient insulin secretion.
- Long-term complications of type 1 diabetes pose significant health challenges.
- Understanding protective mechanisms is crucial for developing novel therapeutic strategies.
Purpose of the Study:
- To investigate the genetic basis of protection in type 1 diabetes survivors.
- To identify molecular interactions that confer resilience to type 1 diabetes complications.
- To explore the role of microRNA in the context of diabetes survival.
Main Methods:
- Utilized induced pluripotent stem cells (iPSCs) derived from type 1 diabetes survivors as genetic models.
- Employed advanced genetic analysis techniques to study cellular mechanisms.
- Investigated the interplay between microRNA and the DNA damage response pathway.
Main Results:
- Identified novel interactions between specific microRNAs and components of the DNA damage checkpoint pathway.
- Demonstrated a potential role for these interactions in conferring protective mechanisms against diabetes-related damage.
- Uncovered genetic factors contributing to resilience in type 1 diabetes survivors.
Conclusions:
- The study highlights a previously unrecognized link between microRNA regulation and DNA damage response in type 1 diabetes.
- These findings suggest that targeting microRNA-DNA damage pathway interactions could offer new avenues for therapeutic intervention.
- Further research into these mechanisms may lead to strategies for preventing or mitigating type 1 diabetes complications.
Related Concept Videos
MicroRNAs
4.3K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.3K
MicroRNAs
24.7K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.7K
MicroRNAs
12.1K
12.1K
Diabetes Mellitus: Overview and Type I Subtype
6.1K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
6.1K
Diabetes Mellitus: Type 2 and Gestational
5.6K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.6K
Pathophysiology of Diabetes
4.5K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
4.5K

